223 related articles for article (PubMed ID: 26468984)
61. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
62. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
63. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.
Sun L; Wang L; Chen T; Yao B; Wang Y; Li Q; Yang W; Liu Z
J Cell Mol Med; 2019 Dec; 23(12):8292-8304. PubMed ID: 31576658
[TBL] [Abstract][Full Text] [Related]
64. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
65. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis.
Peng Z; Ouyang X; Wang Y; Fan Q
BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721
[TBL] [Abstract][Full Text] [Related]
66. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
67. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.
Xiao H; Jiang N; Zhou B; Liu Q; Du C
Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189
[TBL] [Abstract][Full Text] [Related]
68. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.
Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP
Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767
[TBL] [Abstract][Full Text] [Related]
70. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
Tan W; Lim SG; Tan TM
World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
[TBL] [Abstract][Full Text] [Related]
71. Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells.
Chandrakesan P; Yao J; Qu D; May R; Weygant N; Ge Y; Ali N; Sureban SM; Gude M; Vega K; Bannerman-Menson E; Xia L; Bronze M; An G; Houchen CW
Mol Cancer; 2017 Feb; 16(1):30. PubMed ID: 28148261
[TBL] [Abstract][Full Text] [Related]
72. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans.
Yu W; Roy SK; Ma Y; LaVeist TA; Shankar S; Srivastava RK
J Cell Mol Med; 2019 Dec; 23(12):7999-8009. PubMed ID: 31602781
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
[TBL] [Abstract][Full Text] [Related]
75. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
76. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
Li Y; Chen G; Yan Y; Fan Q
Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
[TBL] [Abstract][Full Text] [Related]
77. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
78. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma.
Li S; Peng F; Ning Y; Jiang P; Peng J; Ding X; Zhang J; Jiang T; Xiang S
J Cell Biochem; 2020 Mar; 121(3):2543-2558. PubMed ID: 31696971
[TBL] [Abstract][Full Text] [Related]
79. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X
Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
[TBL] [Abstract][Full Text] [Related]
80. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells.
Li H; Wang N; Xu Y; Chang X; Ke J; Yin J
Bioengineered; 2022 Jan; 13(1):1304-1319. PubMed ID: 34983307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]